UiPath (PATH) reached $11.77 at the closing of the latest trading day, reflecting a -2.04% change compared to its last close.
There is no denying that PATH has missed the first train for Agentic AI monetization, as observed in the decelerating growth hinted by the management's FY2026 guidance. With competition also heating up, it remains to be seen if PATH may report a renewed H2'25 growth opportunity through the recently released Agentic Automation in April 2025. On the other hand, PATH's market leadership in the RPA market remains compelling, significantly aided by the growing ARR and the rich cash flows.
I recommend rotating into catalyst-driven small- and mid-cap stocks like UiPath to protect capital as the S&P 500 hits new highs. UiPath stands out with improving sales momentum, profitability, and a raised full-year outlook, making it a compelling buy despite recent volatility. The company is also growing FCF at a double-digit pace while trading at a very modest ~12x forward FCF.
UiPath (PATH) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
PATH's enterprise AI edge and valuation advantage over APP make it the smarter buy in this AI-driven tech faceoff.
PATH trades well below peers like NOW and PEGA, despite leading RPA adoption across finance, healthcare, and logistics.
As agentic AI and the automation of workplace tasks become a bigger story in the second half, I think it's becoming tough to ignore shares of UiPath (NYSE:PATH) any longer.
UiPath (PATH) concluded the recent trading session at $12.59, signifying a +2.11% move from its prior day's close.
UiPath (PATH) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
PATH's discounted valuation, strong revenue growth and AI-driven automation focus make it a compelling play in enterprise tech.
UiPath (PATH) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
UiPath remains resilient despite generative AI concerns, showing stability and dispelling existential crisis fears. The company boasts strong cash reserves, ongoing share repurchases, and progress toward sustainable GAAP profitability. Agentic automation rollout and high customer retention offer hope for renewed growth, with management optimistic for fiscal 2027.